Liberti L[au] - Search Results

Year	Number of Results
1975	1
1978	1
1980	1
1995	1
2001	1
2003	1
2005	2
2006	1
2007	2
2008	3
2009	4
2010	7
2011	2
2012	5
2013	4
2014	2
2015	7
2016	6
2017	6
2018	5
2019	5
2020	7
2021	3
2022	0

1

Intravenous micronutrient therapy (Myers' Cocktail) for fibromyalgia: a placebo-controlled pilot study.

Ali A, Njike VY, Northrup V, Sabina AB, Williams AL, Liberti LS, Perlman AI, Adelson H, Katz DL. Ali A, et al. Among authors: liberti ls. J Altern Complement Med. 2009 Mar;15(3):247-57. doi: 10.1089/acm.2008.0410. J Altern Complement Med. 2009. PMID: 19250003 Free PMC article. Clinical Trial.

2

Factors related to drug approvals: predictors of outcome?

Liberti L, Breckenridge A, Hoekman J, McAuslane N, Stolk P, Leufkens H. Liberti L, et al. Drug Discov Today. 2017 Jun;22(6):937-946. doi: 10.1016/j.drudis.2017.03.003. Epub 2017 Mar 10. Drug Discov Today. 2017. PMID: 28288783 Review.

3

Benchmarking health technology assessment agencies-methodological challenges and recommendations.

Wang T, Lipska I, McAuslane N, Liberti L, Hövels A, Leufkens H. Wang T, et al. Among authors: liberti l. Int J Technol Assess Health Care. 2020 Sep 8:1-17. doi: 10.1017/S0266462320000598. Online ahead of print. Int J Technol Assess Health Care. 2020. PMID: 32895091

4

Adaptive licensing and facilitated regulatory pathways: A survey of stakeholder perceptions.

Liberti L, Stolk P, McAuslane N, Somauroo A, Breckenridge AM, Leufkens HG. Liberti L, et al. Clin Pharmacol Ther. 2015 Nov;98(5):477-9. doi: 10.1002/cpt.140. Epub 2015 Jun 30. Clin Pharmacol Ther. 2015. PMID: 25877216 Review. No abstract available.

5

Accelerated approval of medicines: fit for purpose?

Breckenridge A, Liberti L. Breckenridge A, et al. Among authors: liberti l. Nat Rev Drug Discov. 2018 Jun;17(6):379-380. doi: 10.1038/nrd.2017.245. Epub 2018 Jan 5. Nat Rev Drug Discov. 2018. PMID: 29302066

6

The Confluence of Accelerated Regulatory and Health Technology Assessment Access Pathways.

McAuslane N, Liberti L, Connelly P. McAuslane N, et al. Among authors: liberti l. Clin Pharmacol Ther. 2019 Apr;105(4):935-942. doi: 10.1002/cpt.1315. Epub 2019 Jan 16. Clin Pharmacol Ther. 2019. PMID: 30472729 Review.

7

A Baseline Analysis of Regulatory Review Timelines for ANVISA: 2013-2016.

Patel P, Cerqueira DM, Santos GML, de Lima Soares R, Sousa VD, Liberti L, McAuslane N. Patel P, et al. Among authors: liberti l. Ther Innov Regul Sci. 2020 Nov;54(6):1428-1435. doi: 10.1007/s43441-020-00169-5. Epub 2020 Jun 9. Ther Innov Regul Sci. 2020. PMID: 32519282 Free PMC article.

8

Minimal NMR distance information for rigidity of protein graphs.

Lavor C, Liberti L, Donald B, Worley B, Bardiaux B, Malliavin TE, Nilges M. Lavor C, et al. Among authors: liberti l. Discrete Appl Math. 2019 Mar 15;256:91-104. doi: 10.1016/j.dam.2018.03.071. Epub 2018 Apr 26. Discrete Appl Math. 2019. PMID: 30799888 Free PMC article.

9

Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative.

Giaquinto AR, Grignolo A, Liberti L, Lim JCW, Salmonson T, Sauer F, Ukwu H. Giaquinto AR, et al. Among authors: liberti l. PLoS Med. 2020 Aug 12;17(8):e1003092. doi: 10.1371/journal.pmed.1003092. eCollection 2020 Aug. PLoS Med. 2020. PMID: 32785224 Free PMC article. Review.

10

The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested Solutions.

Bujar M, McAuslane N, Liberti L. Bujar M, et al. Among authors: liberti l. Pharmaceut Med. 2021 Mar;35(2):113-122. doi: 10.1007/s40290-020-00372-7. Epub 2021 Feb 4. Pharmaceut Med. 2021. PMID: 33537899 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results